1 min to read News Posted on May 18, 2023 PTC, chasing BioMarin, posts phase 3 rare disease win but fails to … – FierceBiotech PTC, chasing BioMarin, posts phase 3 rare disease win but fails to … FierceBiotech Source: PTC, chasing BioMarin, posts phase 3 rare disease win but fails to … – FierceBiotech share tweet share How a SPAC works?Why Buy a SPAC Before It Identifies a Target?By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawSPACs: Are You Really Ready To Commit? Tags: SPACs